Variation in CAPN10 in relation to type 2 diabetes, obesity and quantitative metabolic traits: Studies in 6018 whites (Q57731029)

7

0 references

Torben Jørgensen

object named as

Torben Jørgensen

5

0 references

Hans Eiberg

3

object named as

Hans Eiberg

0 references

author name string

Dorit P. Jensen

1

0 references

Søren A. Urhammer

2

0 references

Knut Borch-Johnsen

Molecular Genetics and Metabolism

4

0 references

publication date

December 2006

0 references

published in

0 references

volume

89

0 references

issue

4

0 references

page(s)

360-367

0 references

cites work

A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2.

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpain: a protease in search of a function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Structure and physiological function of calpains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpains play a role in insulin secretion and action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpain inhibition and insulin action in cultured human muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variation in three single nucleotide polymorphisms in the calpain-10 gene not associated with type 2 diabetes in a large Finnish cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpain 10 and type 2 diabetes: are we getting closer to an explanation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Association of the calpain-10 gene with type 2 diabetes mellitus in a Mexican population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetic prediction of future type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variation in the calpain-10 gene affects blood glucose levels in the British population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Functional significance of the UCSNP-43 polymorphism in the CAPN10 gene for proinsulin processing and insulin secretion in nondiabetic Germans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variation in the calpain-10 gene is associated with elevated triglyceride levels and reduced adipose tissue messenger ribonucleic acid expression in obese Swedish subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

No evidence for involvement of the calpain-10 gene `high-risk' haplotype combination for non-insulin-dependent diabetes mellitus in early onset obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

The functional Thr130Ile and Val255Met polymorphisms of the hepatocyte nuclear factor-4alpha (HNF4A): gene associations with type 2 diabetes or altered beta-cell function among Danes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Bias in meta-analysis detected by a simple, graphical test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetics of common forms of glycaemia with pathological impact on vascular biology: are we on the right track?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetics of type 2 diabetes mellitus: status and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Calpain-10 gene polymorphisms and type 2 diabetes in West Africans: the Africa America Diabetes Mellitus (AADM) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Variants of calpain-10 gene and its association with type 2 diabetes mellitus in a Chinese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003

Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.YMGME.2006.06.003